Learn more

PROCELL THERAPEUTICS INC

Overview
  • Total Patents
    62
  • GoodIP Patent Rank
    61,602
About

PROCELL THERAPEUTICS INC has a total of 62 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are CUE BIOPHARMA INC, DEMETER BIOTECH LTD and DUCENTIS BIOTHERAPEUTICS LTD.

Patent filings per year

Chart showing PROCELL THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lee Byung Kyu 31
#2 Lim Jung Hee 28
#3 Jo Dae Woong 15
#4 Lee Kang Jin 13
#5 Jo Daewoong 13
#6 Lim Jung-Hee 10
#7 Do Thi Thuy Nga 10
#8 Duong Minh Tam 9
#9 Shin Ki Deok 9
#10 Kim Jin Sook 8

Latest patents

Publication Filing date Title
KR20170002475A Novel cell penetrating peptide, conjugate thereof with botulinum toxin, and use thereof
WO2016006744A1 Peptide-sirna complex for transdermal delivery using intracellular molecular transport peptide, and use thereof
WO2013077680A1 Development of novel macromolecule transduction domain with improved cell permeability and method for using same
KR20130070607A Transdermal delivery system of dermatological active ingredients using cellular transduction peptides
KR101258279B1 Development of the macromolecule transduction domain with improved cell permeability and its applications
WO2012050402A2 Cell-permeable recombinant parkin protein and a pharmaceutical composition for treating degenerative brain diseases containing the same
EP2407488A2 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy
KR20110016867A Cell-permeable p27 recombinant protein, a polynucleotide that codes the same and an anti-cancer composition containing the same as an active ingredient
WO2009145489A2 Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component
KR20100093523A Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same
WO2009031835A2 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
KR100887266B1 Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same
EP2132225A1 Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells